SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Acquisition

25 Sep 2012 07:00

RNS Number : 0548N
Rentokil Initial PLC
25 September 2012
 



 

 

 

25 September 2012

 

Rentokil Initial acquires the assets of Western Exterminator Company

 

Rentokil Initial plc ("Rentokil") (LSE: RTO) today announces that it has agreed to acquire the assets of Western Exterminator Company ("Western"), a leading pest control company on the US West Coast, for an initial cash consideration of $99.6m, with a deferred consideration of up to $15.0m payable within 18 months, from existing financial facilities.

 

Rentokil will become the third largest pest control company in the North American market with pro-forma annualised revenues of $330m in pest control services (with coast to coast coverage) and $90m in speciality chemical products distribution.

 

Western has two divisions:

 

·; The Pest Control division has 36 offices located primarily in California and the adjacent states of Arizona and Nevada. It provides Rentokil with an entrance into these states with a population of 46m people.

 

·; The Products division is a leading wholesale distributor of specialty chemicals serving the West Coast and central regions of the US, providing products and supplies to the pest control, landscape, golf course and nursery industries. This division complements our existing specialty chemical products division which serves the East Coast of the US.

 

The acquisition is consistent with Rentokil's strategy, outlined in November 2011, of targeting pest control acquisitions in North America, Latin America and the Middle East.

 

The total book value of the gross assets to be acquired is $36.7m. In the year to 31 December 2011 the business acquired generated EBITA of $4.1m on revenues of approximately $149.0m (60% Pest Control: 40% Products).

 

The deferred consideration will be payable subject to certain working capital and other adjustments, including warranty and/or indemnity claims.

 

The acquisition is expected to complete later this year subject to receipt of the relevant regulatory clearances. The transaction will be EPS accretive in year one. The profitability of Western will be improved significantly by leveraging Rentokil's commercial and operational management capabilities to bring Western's operating margins into line with Rentokil's current North American Pest Control business.

 

Alan Brown, Chief Executive of Rentokil Initial plc, said:

 

"This acquisition significantly increases Rentokil's footprint in the World's largest pest control market and enables us to compete more effectively, particularly for customers looking for nationwide coverage in pest control or specialty chemical distribution capability.

 

"Western has service and quality levels that are among the best in the industry. It is rightly proud of its 90-year tradition and reputation.

 

"We have taken our US Pest Control and Products business from revenue of less than $30million to $420million through a series of successful acquisitions, most notably JC Ehrlich, Presto-X and now Western over the last seven years."

 

Ends

Note: A presentation with additional information about Western Exterminator can be found at www.rentokil-initial.com/investors/presentations

 

About Rentokil Initial plc

 

Rentokil Initial is one of the largest business services companies in the world, operating in all the major economies of Europe, North America, Asia Pacific and Africa. The Company has some 66,000 employees providing a range of support services in over 60 countries.

 

www.rentokil-initial.com

 

www.westernexterminator.com

 

www.target-specialty.com

 

 

Enquiries:

 

Investors / Analysts enquiries:

Katharine Rycroft, Head of Investor Relations Rentokil Initial plc 01293 858 166

 

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978 199

Kate Holgate/ Catriona McDermott Brunswick Group 020 7404 5959

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUVUSRUWAKURR
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.